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rotein modiﬁcation by the ubiquitin-like SUMO protein
contributes to many cellular regulatory mechanisms.
 
In 
 
Saccharomyces cerevisiae
 
, both sumoylating and
desumoylating activities are essential for viability. Of its
two known desumoylating enzymes, Ubl-speciﬁc protease
(Ulp)1 and Ulp2/Smt4, Ulp1 is speciﬁcally required for cell
 
cycle progression. A 
 
 
 
200-residue segment, the Ulp domain
(UD), is conserved among Ulps and includes a core cysteine
protease domain that is even more widespread. Here we
demonstrate that the Ulp1 UD by itself can support wild-type
growth rates and in vitro can cleave SUMO from substrates.
However, in cells expressing only the UD of Ulp1, many
SUMO conjugates accumulate to high levels, indicating
P
 
that the nonessential Ulp1 NH
 
2
 
-terminal domain is important
for activity against a substantial fraction of sumoylated targets.
The NH
 
2
 
-terminal domain also includes sequences necessary
and sufﬁcient to concentrate Ulp1 at nuclear envelope
sites. Remarkably, NH
 
2
 
-terminally deleted Ulp1 variants
are able, unlike full-length Ulp1, to suppress defects of
cells lacking the divergent Ulp2 isopeptidase. Thus, the
 
NH
 
2
 
-terminal regulatory domain of Ulp1 restricts Ulp1
activity toward certain sumoylated proteins while enabling
the cleavage of others. These data deﬁne key functional
elements of Ulp1 and strongly suggest that subcellular local-
ization is a physiologically signiﬁcant constraint on SUMO
isopeptidase speciﬁcity.
 
Introduction
 
Many cellular processes in eukaryotes depend on covalent
modification of specific proteins by ubiquitin (for review see
Hochstrasser, 1996; Pickart, 2001; Weissman, 2001). Attach-
ment of ubiquitin to proteins changes their functional
properties in ways that are only partly understood, but in
general it appears to alter the ability of the modified protein
to interact with other macromolecules. For example, when a
protein is modified by a polymeric chain of ubiquitins, its
affinity for the proteasome is greatly increased. This large
protease cleaves the protein into short peptides and releases
the ubiquitin tag. Eukaryotes also express a set of functionally
diverse ubiquitin-like proteins (Ubls).* Ubls are significantly
diverged from ubiquitin yet are also ligated to other proteins
(for review see Hochstrasser, 2000; Jentsch and Pyrowolakis,
2000). An intensely studied Ubl is the vertebrate SUMO-1
protein (Melchior, 2000; Hochstrasser, 2001; Kim et al.,
 
2002). Human SUMO-1 shares 
 
 
 
20% identity with ubiquitin
but is 48% identical to a yeast protein called Smt3. SUMO-1
and Smt3 both have the ubiquitin fold (Bayer et al., 1998;
Mossessova and Lima, 2000). Analogous to ubiquitin ligation,
a cascade of three enzymes (E1, E2, and E3) catalyzes amide
(isopeptide) bond formation between the COOH-terminal
carboxyl group of SUMO and lysine side chains of acceptor
proteins. Conjugation of substrates to Smt3/SUMO has
been shown to depend on an E1-related enzyme, the Uba2-
Aos1 heterodimer, an E2-like enzyme, Ubc9, and sev-
eral distinct E3-like factors (Kim et al., 2002). Vertebrates
have two additional highly similar proteins, SUMO-2 and
 
SUMO-3, which are 
 
 
 
45% identical to SUMO-1 and are
thought to utilize the same E1 and E2 enzymes that act on
SUMO-1 (Saitoh and Hinchey, 2000).
The SUMO system has been implicated in multiple physio-
logical pathways in both yeast and other eukaryotes (Melchior,
 
2000; Hochstrasser, 2001; Kim et al., 2002). In the yeast
 
Saccharomyces cerevisiae
 
, many SUMO system components
are essential for viability, principally because of their require-
ment for cell cycle progression (Seufert et al., 1995; Li and
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Hochstrasser, 1999). Although several dozen substrates for
SUMO attachment have been identified in metazoan cells,
the physiological importance of SUMO attachment to most
of these specific proteins is unknown (Melchior, 2000).
Only a handful of yeast Smt3 substrates are known. The first
was a subset of the septins, which are proteins essential for
cytokinesis; however, eliminating septin sumoylation had no
detectable phenotypic effect (Johnson and Blobel, 1999; Ta-
kahashi et al., 1999;
 
 
 
Johnson and Gupta, 2001). Yeast topo-
isomerase II can be sumoylated, and this modification, al-
though not required for the essential function of the enzyme,
appears to contribute in some way to the elastic or cohesive
properties of centromeres (Bachant et al., 2002). Smt3 can
also be ligated to the DNA replication/repair protein PCNA,
and this may negatively regulate the DNA repair activity of
PCNA (Hoege et al., 2002).
Modification of proteins by ubiquitin and Ubls is usually
reversible. Moreover, ubiquitin and most Ubls are synthe-
sized in precursor forms, with one or more amino acids fol-
lowing what will become the mature COOH terminus.
Ubiquitin substrate deconjugation and precursor processing
are performed by members of a diverse group of specialized
proteases called deubiquitinating enzymes or Dubs (Wilkin-
son and Hochstrasser, 1998; Chung and Baek, 1999). Analy-
ses of these enzymes indicate that they have diverse regulatory
roles in the ubiquitin system. Much less is known about the
analogous enzymes that act on the SUMO proteins. We ini-
tially identified a 
 
S.
 
 
 
cerevisiae
 
 enzyme, Ubl-specific protease
(Ulp)1, which specifically removes SUMO from proteins and
is required for cell cycle progression (Li and Hochstrasser,
1999). Ulp1 lacks obvious sequence similarity to any known
Dub and is unable to process ubiquitin-linked substrates.
Numerous proven or putative desumoylating enzymes
have been identified in the sequence databases based on their
similarity to an 
 
 
 
200-residue COOH-terminal domain in
Ulp1 (the Ulp domain [UD]). These enzymes include mul-
tiple proteins from humans and one additional protein in 
 
S.
cerevisiae
 
 (Li and Hochstrasser, 1999; Gong et al., 2000; Li
and Hochstrasser, 2000). The Ulp1-related yeast protein,
Ulp2/Smt4, was subsequently shown to have desumoylating
activity (Li and Hochstrasser, 2000). Within the UD is a
more widely conserved segment referred to as the core do-
main, which shares limited sequence similarity to viral cys-
teine proteases (Ding et al., 1996; Stephens et al., 1998; Li
and Hochstrasser, 1999). The active site residues within this
core domain of Ulp1 and Ulp2 are indeed necessary for cat-
alytic activity and in vivo function (Li and Hochstrasser,
1999; Strunnikov et al., 2001). Ulp1 is required for cell cy-
cle progression, whereas Ulp2, although not essential, is re-
quired for normal chromosome stability and for recovery
from cell cycle checkpoint arrest (Li and Hochstrasser, 2000;
Strunnikov et al., 2001; Bachant et al., 2002).
An important unanswered question about the desumoylat-
ing enzymes concerns the basis of their in vivo substrate spec-
ificities. The patterns of SUMO–protein conjugates in
 
ulp1-ts
 
 and 
 
ulp2
 
 
 
 mutants are dissimilar, as are their cellular
phenotypes, indicating that the two yeast SUMO isopepti-
dases have distinct specificities (Li and Hochstrasser, 2000).
Ulp2 has very weak activity in vitro and is unable to compensate
for loss of Ulp1 in vivo even when overproduced. Ulp1, on
 
the other hand, can act in vitro on the Smt3 conjugates that
accumulate to high levels in 
 
ulp2
 
 
 
 cells, and at moderately
high dosage 
 
ULP1
 
 can suppress some phenotypic abnormali-
ties of the 
 
ulp2
 
 
 
 mutant (Li and Hochstrasser, 2000). This
suggests that Ulp1 activity is somehow constrained in the cell
to prevent it from acting on Ulp2 substrates.
Here we show that the conserved UD of Ulp1 is sufficient
for its essential in vivo function. However, the NH
 
2
 
-termi-
nal domain is required both for localization of Ulp1 to the
nuclear pore complex (NPC) and for desumoylation of
many Ulp1 substrates. Remarkably, when Ulp1 is delocal-
ized in the cell by NH
 
2
 
-terminal deletion, it acquires the
ability to desumoylate proteins that are normally targets of
the Ulp2 enzyme and to suppress phenotypic abnormalities
associated with loss of Ulp2. Thus, the net effect in vivo of
removing the NH
 
2
 
-terminal domain of Ulp1 is a broad
switch in substrate specificity, with loss of targeting to a sig-
nificant subset of Ulp1 substrates and gain of activity toward
what are normally Ulp2-restricted substrates.
 
Results
 
The UD of Ulp1 is sufficient for cell viability 
and catalytic activity
 
Loss of Ulp1 is lethal in 
 
S. cerevisiae
 
 because the mutant cells
are unable to traverse the G2/M phase of the cell cycle effi-
ciently (Li and Hochstrasser, 1999). The Smt3-cleaving ac-
tivity of the 621-residue Ulp1 enzyme is necessary for this
essential in vivo function (Fig. 1). We asked whether any
segments NH
 
2
 
-terminal to the catalytic domain (UD) could
be deleted without loss of viability. A previous study had
suggested that the UD by itself was insufficient for viability
and, moreover, behaved as a dominant lethal (Mossessova
and Lima, 2000). We were therefore surprised when we
found that deletions could be extended as far as residue 417
(ulp1-C204) without a significant effect on growth rate at
30
 
 
 
C (Fig. 1). Mutant ulp1-C204 protein consists of the
UD and little else. These experiments were performed with
 
ulp1
 
 alleles on low copy plasmids. When ulp1-C204 was in-
tegrated into the chromosome (at the 
 
LEU2
 
 locus), viability
was still seen although growth was slower than for wild-type
cells, presumably because of lower ulp1-C204 expression
levels (unpublished data). The differences in viability ob-
served between studies appear to be due to properties of the
specific constructs used (see Discussion).
The growth-complementing activity of ulp1-C204 re-
quired a catalytically active UD. When the active site cys-
teine in the ulp1-C204 construct was mutated to create
ulp1-C204(C580S), viability of 
 
ulp1
 
 
 
 cells was no longer
rescued. If the region of the UD upstream of the active site
catalytic residues was deleted (ulp1-C173), the mutant also
behaved as a null (Fig. 1). This part of the UD makes ex-
tensive contacts with Smt3 in the Ulp1-Smt3 cocrystal
structure as had been predicted from sequence conserva-
tion among the diverse Ulps (Li and Hochstrasser, 1999;
Mossessova and Lima, 2000). Therefore, the ulp1-C173
protein would be predicted to lack desumoylating activity as
was found (Fig. 2 A). A deletion allele expressing only the
NH
 
2
 
-terminal domain of Ulp1, ulp1-N417, also failed to
complement the 
 
ulp1
 
 
 
 strain (Fig. 1). Protein expression ofT
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Figure 1. Deletion analysis of the Ulp1 protein. (A) The set of terminal Ulp1 deletions used in the present work. Gray boxes represent the 
UD. Positions of the catalytic His514 and Cys580 residues and the C580S mutation are indicated. CC, potential coiled-coil region (aa 346–404). 
Catalytic activity of recombinant GST-Ulp1 deletion proteins purified from bacterial cells was determined by in vitro processing of an 
35S-labeled His6-ubiquitin-Smt3-HA chimeric substrate (see Fig. 2 A). (B) Complementation analysis of each deletion allele was done in a 
ulp1  strain by plasmid shuffling. Strain MHY1321 (ulp1 ), which carries the wild-type ULP1 gene in a YCp50 (CEN, URA3) plasmid, was 
transformed with YCplac22 (TRP1)-based plasmids bearing the various ulp1 deletion alleles. Trp
  transformants were then streaked on 5-FOA 
plates and incubated at 30 C for 3 d to determine the ability of the different ULP1 deletions to support growth.T
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the various deletion constructs varied over a very small range
(Fig. 2 D and unpublished data).
We assayed Smt3-cleaving activity of all the Ulp1 deletion
proteins. The alleles were fused with the coding sequence for
GST, and the fusion proteins were expressed in 
 
Escherichia
coli
 
 and purified by glutathione-Sepharose affinity chroma-
tography. Processing of an 
 
35
 
S-labeled His
 
6
 
-ubiquitin-Smt3-
HA chimera was assayed by SDS-PAGE. Smt3 cleavage in
vitro and growth complementation of 
 
ulp1
 
 
 
 yeast correlated
exactly (Fig. 1 and Fig. 2 A). Ulp1-C204 activity was lower
than that of the full-length protein (Fig. 2 A). Kinetic analy-
sis of His
 
6
 
-ubiquitin-Smt3-HA processing between the Smt3
and HA segments yielded values for v
 
obs
 
 of 66 min
 
 
 
1
 
 for
GST-Ulp1 and 7.3 min
 
 
 
1
 
 for GST-ulp1-C204. Processing
in yeast cells of the natural COOH-terminal tripeptide Ala-
Thr-Tyr from the Smt3 precursor was also tested (Fig. 2 B).
This cleavage, which is due primarily to Ulp1 and not Ulp2
(Li and Hochstrasser, 2000), was slower in cells expressing
ulp1-C204 than in those with full-length Ulp1 (Fig. 2 B and
Fig. 3 B). On the other hand, Smt3 cleavage in vitro by all
the other Ulp1 COOH-terminal fragments shown in Fig. 1
A was indistinguishable from cleavage by full-length Ulp1
with the possible exception of ulp1-C275, which was slightly
slower (unpublished data). The activity of these fragments
when overproduced in yeast also appeared to be comparable
to that of full-length Ulp1 (see Fig. 4 A). In summary, the
COOH-terminal catalytic domain of Ulp1 is both necessary
and sufficient for the essential function of the protein in cell
cycle progression and for Smt3 precursor cleavage.
 
The noncatalytic domain of Ulp1 contributes to 
substrate specificity
 
Although the NH
 
2
 
-terminal two-thirds of Ulp1 was dispens-
able for viability, loss of this region led to a striking accumu-
lation of Smt3–protein conjugates (Fig. 2 C). Importantly,
progressive deletion of segments from the NH
 
2
 
 terminus of
Ulp1 caused a generally progressive increase in levels of high
molecular mass Smt3–protein species. Even the smallest de-
letion, ulp1-C478, resulted in a mild accumulation of con-
jugates above the wild-type level despite the fact that, as
noted above, this Ulp1 derivative has wild-type levels of
Smt3 processing activity, at least in vitro. A sharp increase in
the levels of Smt3 conjugates with many distinct new species
was seen between the ulp1-C459 and -C449 transformants.
Figure 2. Comparison of Ulp1 catalytic 
activity in vitro and function in vivo. 
(A) Enzymatic activity of selected GST-
Ulp1 derivatives. Cleavage of purified 
35S-labeled His6-ubiquitin-Smt3-HA by 
purified GST fusions was assayed at 
30 C for 30 min and stopped by addition 
of SDS-loading buffer. (B) In vivo 
processing of HA-Smt3-aty. MHY1321 
cells carrying pRS425-HA-Smt3-aty and 
either wild-type ULP1 or ulp1-C204 in 
YCplac22 were pulse labeled with 
35S-Translabel for 5 min and chased in 
buffer containing cycloheximide and an 
excess of unlabeled methionine. At the 
indicated time points, aliquots of cells 
were withdrawn and processed for 
immunoprecipitation with anti-HA 
antibodies. The positions of precursor 
HA-Smt3-aty and the processed product 
are indicated. Because of the efficiency 
of processing, it is often difficult to 
detect precursor in ULP1 cells at the initial 
time point. (C) Smt3 protein profiles 
of ulp1  (MHY1321) cells carrying the 
indicated plasmids with different Ulp1 
deletions. Cell extracts were fractionated 
through an 11–14% gradient SDS gel 
and assayed by immunoblotting with a 
polyclonal anti-Smt3 antiserum. The 
membrane was reprobed with anti-PGK 
(phosphoglycerate kinase) to compare 
the protein loading (bottom). Positions of 
marker proteins (kD) are indicated on 
the left. (D) Anti-MYC immunoblot 
showing expression levels of MYC9-
tagged Ulp1 derivatives. ULP1 alleles 
used the ULP1 promoter and were based 
in YCplac22. COOH-terminally MYC9-tagged Ulp1, C478, C459, C449, C275, and C204 proteins, which were indistinguishable in growth 
from the untagged alleles use in C, were expressed in strain MHY1321 (ulp1 ). The recessive lethal alleles encoding the catalytically inactive 
Ulp1-N417-MYC9 and Ulp1-C173-MYC9 proteins were expressed in congenic wild-type MHY500 cells. (Bottom) The same membrane 
reprobed with anti-PGK antibody.T
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Figure 3. Contribution of the Ulp1 NH2 
terminus to substrate recognition. 
(A) Overproduction of GST-Ulp1N417 and 
GST-Ulp1N255i leads to accumulation 
of sumoylated proteins. Strains and growth 
conditions as in B, but induction was for 
6 h. Molecular mass markers are indicated. 
The vertical line denotes Smt3 protein 
conjugates. In the bottom panel, the filter 
was reprobed with anti-PGK antibody. 
(B) Overproduction of GST-Ulp1N417 
inhibits Smt3 precursor processing. 
Mid-log phase cultures of wild-type 
MHY500 cells carrying pEMBL-GST-
Ulp1N417, pGal4-ER-VP16 and pRS425-
HA-Smt3-aty in selective medium were 
either induced with 100 nM  -estradiol 
( N417) or not induced (–N417) for 
GST-Ulp1-N417 overproduction. After 4 h, 
the cells were collected by centrifugation 
and subjected to pulse–chase analysis. 
(C) Aliquots of 10-fold serially diluted 
cells carrying either empty vector 
(pEMBL-GST) or GAL1-driven alleles 
encoding Ulp1 NH2-terminal deletions 
were spotted to minimal plates containing 
glucose or galactose and incubated at 
30 C for 4 d.
 
The data cannot be explained by differences in protein ex-
pression, since these were all fairly small (Fig. 2 D). There-
fore, the results imply that the NH
 
2
 
-terminal domain of
Ulp1 bears multiple determinants for substrate discrimina-
tion, which might act either directly or indirectly in sub-
strate binding. A few exceptions to the monotonic increase
in Smt3 conjugates can be seen in Fig. 2 C. For instance, a
30-kD species accumulated in cells with ulp1-C449 but not
in -C275 or -C204, even though the latter two proteins were
missing larger NH
 
2
 
-terminal segments. This gave a first hint
that the regulatory NH
 
2
 
-terminal domain of Ulp1 might
contain both elements that act positively and ones that act
negatively on Smt3–protein cleavage, depending on the con-
jugate (see below).
If the NH
 
2
 
-terminal domain of Ulp1 (ulp1-N417) con-
tains sites for substrate interaction, then overproduction of
this protein fragment might be able to compete with endog-
enous full-length Ulp1 for Smt3–conjugate binding. A se-T
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quence encoding a fusion between GST and N417 was
placed under the control of the galactose-inducible 
 
GAL1
 
promoter and expressed in wild-type yeast cells. As can be
seen in Fig. 3 A (lane 2), this resulted in a pronounced accu-
mulation of Smt3–protein conjugates. This was not seen in
cells overproducing only GST (lane 1). Overproduction of
ulp1-N417 also impaired Smt3 precursor processing (Fig. 3
B). Smaller Ulp1 subfragments (Fig. 3 C) tested in the same
way localized the region responsible for this dominant-nega-
tive effect to residues 163–417 (N255i; Fig. 3 A, lane 3).
The putative coiled coil region was necessary for strong
growth inhibition. Competition between ulp1-N417 or
ulp1-N255i and endogenous Ulp1 for Smt3 or Smt3–pro-
tein substrates would be expected to be detrimental to cell
growth. In fact, strong inhibition of cell growth correlated
closely with the ability of the NH
 
2
 
-terminal Ulp1 fragments
to impair Smt3–protein deconjugation in vivo (Fig. 3 C).
The ability of the overproduced noncatalytic domain of
Ulp1 to slow Smt3 precursor processing suggested either that
this domain could bind to and inhibit the function of Ulp1
or that it could bind Smt3 itself (or both). (The possibility
that this overproduced domain could compete with Ulp1 for
NPC binding [see below] was not supported by immunoflu-
orescence analysis of Ulp1-MYC in cells overproducing ulp1-
N417 [unpublished data], although interference with an-
 
other aspect of NPC function is possible.) Neither two-
hybrid analysis nor GST pull-down assays suggested a stable
interaction between the NH
 
2
 
-terminal domain and either the
COOH-terminal domain or full-length Ulp1 (unpublished
data). Based on GST pull-down assays, ulp1-N417 was able
to bind what appeared to be free Smt3 and a small number of
Smt3 conjugates in yeast cells, but the amount of copurified
Smt3 proteins varied between experiments (unpublished
data). Therefore, clarification of the exact mechanism behind
the dominant-negative effect seen with the Ulp1 NH
 
2
 
-termi-
nal domain will require additional studies.
We conclude that the noncatalytic domain of Ulp1 makes
a significant contribution to substrate recognition in vivo.
This may depend in part on the ability of this domain of the
enzyme to bind Smt3, but other more indirect roles in mod-
ulating substrate specificity would be consistent with the
data as well (see below).
 
Overproduction of active Ulp1 is toxic to yeast
 
Interestingly, high levels of full-length Ulp1 also impaired
yeast growth (Fig. 3 C and Fig. 4 B). However, in this case a
depression of Smt3–protein conjugates was observed (Fig. 4
A, lanes 1 and 2). This reduction in conjugates upon acute
induction of Ulp1 expression required the desumoylating
activity of Ulp1, since hyperaccumulation of these species,
Figure 4. High level expression of Ulp1 or Ulp1 
mutants is detrimental to cell growth. (A) Anti-Smt3 
immunoblot of a subset of strains shown in B 
except that cells also carried a plasmid encoding a 
Gal4-ER-VP16 fusion protein, which allowed high 
level expression of the GST fusions in glucose 
medium through gratuitous induction of GAL1-
driven genes by addition of  -estradiol. The cells 
were induced for 4 h at 30 C, and similar expression 
levels of the GST fusions were confirmed by anti-GST 
immunoblotting (not depicted). Positions of the 
molecular mass standards are shown on the left. 
(Bottom) Anti-PGK immunoblot of the same filter. 
(B) 10-fold serial dilutions of mid-log phase 
wild-type MHY500 cells transformed with plasmids 
expressing full-length GST-Ulp1 or different GST-
Ulp1 deletions from plasmid-born alleles under the 
control of a GAL1 promoter. Cells were spotted 
onto URA drop-out plates containing either 
glucose or galactose and incubated for 4 d at 30 C.T
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rather than a reduction, was observed with the catalytically
inactive ulp1-C580S mutant (Fig. 4 A, lane 3). Chronic
overproduction of catalytically active COOH-terminal frag-
ments of Ulp1 also strongly inhibited cell growth (Fig. 4 B).
These overproduced fragments strongly reduced levels of
bulk sumoylated proteins (Fig. 4 A, lanes 5–7). This con-
trasted with the observation that these same Ulp1 deriva-
tives, when present at near endogenous levels of expression,
were greatly impaired in their ability to act on the bulk of
detectable Ulp1 targets (Fig. 2 C).
The implication is that at a high enough concentration,
the catalytic domain of Ulp1 by itself and the full-length
protein can act relatively promiscuously without the usual
constraints on its activity that are imposed at normal Ulp1
expression levels. These constraints might include endoge-
nous inhibitors of Ulp1 and/or a restricted subcellular distri-
bution. Loss of this restriction on Ulp1 activity is also evi-
dent in lysates from 
 
ulp2
 
 
 
 cells where the endogenous Ulp1
 
can cleave the 
 
ulp2
 
 
 
-specific Smt3 conjugates that had accu-
mulated in vivo (Li and Hochstrasser, 2000).
 
The NH
 
2
 
-terminal domain of Ulp1 localizes it 
to the nuclear envelope
 
As noted above, the isolated catalytic domain of Ulp1 is un-
able to cleave many cellular Smt3–protein conjugates effi-
ciently (Fig. 2 C); yet at high concentration, it can still
strongly reduce levels of most of these conjugates (Fig. 4 A).
A possible explanation of these unexpected results is that the
noncatalytic domain normally localizes the enzyme to spe-
cific sites in the cell where these Smt3 conjugates are also
concentrated. However, at sufficiently high levels the delo-
calized enzyme lacking the noncatalytic domain could still
encounter its normal targets. We examined this possibility
by tagging Ulp1 and its derivatives with nine copies of the
MYC epitope (Li and Hochstrasser, 2000), which allowed
localization by immunofluorescence microscopy. All MYC-
Figure 5. Subcellular localization of Ulp1 deletion derivatives. Localization of MYC9-tagged Ulp1 proteins by indirect immunofluorescence. 
Strains and plasmids were the same as in the legend to Fig. 2 D. Nuclei were stained with DAPI.T
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Figure 6. The NH2-terminal domain of Ulp1 
constrains its in vivo substrate specificity. 
(A) Smt3 protein conjugates in MHY1380 ulp2  
cells carrying YCplac22-based plasmids with 
different ULP1 deletions or full-length ULP1 or 
ULP2. Cell lysates were fractionated by gradient 
SDS-PAGE. Positions of molecular mass markers 
are shown at left. The asterisks on the right 
indicate prominent sumoylated protein species 
observed in the ulp2 /vector lane but not in the 
lanes from cells transformed with certain ULP1 
deletions (C459, C275, and/or C204). The double 
asterisk highlights a sumoylated protein found at 
higher levels upon expression of the above three 
ULP1 deletions. This might reflect incomplete 
removal of Smt3 from a substrate modified with 
multiple Smt3 molecules. (Bottom) The same 
filter reprobed with anti-PGK antibody. (B) Ulp1 
NH2-terminal deletions can suppress ulp2  
phenotypic defects. Strains used are the same as 
in A. For each strain, aliquots from 10-fold serial 
dilutions were spotted onto YPD plates (rich 
media) incubated at 30 C or 37 C and onto 
plates containing 0.1 M HU, or 20  g/ml 
benomyl sulfate and incubated at 30 C for 5 d.
tagged Ulp1 constructs that had an intact UD fully comple-
mented the lethality of a ulp1  strain.
Full-length Ulp1 and ulp1-C478 proteins contained a
consensus bipartite nuclear localization signal (NLS) and lo-
calized predominantly to the nuclear envelope, which was
visible as a ring-like perinuclear fluorescence (Fig. 5). As
seen previously, this rim staining was punctate (Li and
Hochstrasser, 2000), which reflects Ulp1 binding to NPCs
(Schwienhorst et al., 2000; Takahashi et al., 2000). The
ulp1-C459 protein showed a detectable but less pronounced
nuclear envelope localization, whereas ulp1-C449, which
lacks the entire NLS, no longer concentrated clearly in a rim
around the nucleus, although bright spots of stain on the pe-
rimeter of the nucleus were often seen. This transition from
strong localization at NPCs to a more disperse distribution
coincided with the strong increase in Smt3 conjugate accu-
mulation seen with the same deletions (Fig. 2 C). Moreover,
the ulp1-C275 and ulp1-C204 proteins no longer localized
detectably at the nuclear rim (Fig. 5), and high levels of
Smt3 conjugates accumulated in ulp1  cells expressing these
derivatives (Fig. 2 C).
We conclude that the NH2-terminal domain of Ulp1, par-
ticularly residues between positions 144–346, are necessary
for nuclear envelope localization. The ability to localize to the
envelope correlated closely with the ability of the Ulp1 deriv-
ative to cleave many Smt3 conjugates efficiently, suggesting a
close link between these two properties. However, localiza-
tion of Ulp1 to NPCs cannot explain all of its substrate-tar-
geting features. First, the COOH-terminal UD retains the
capacity to act on at least the essential targets of Ulp1 in vivo
despite failing to localize appreciably to NPCs. Second, as
noted earlier the accumulation of a small subset of Smt3 con-
jugates did not correlate with Ulp1 delocalization.
The above results indicate that the NH2-terminal domain
is necessary for Ulp1 localization to the NPC. Conversely,
ulp1-N417 (Fig. 5) and ulp1-N346 (unpublished data),
which were missing the entire UD, were still able to concen-
trate at the nuclear envelope like the full-length protein, in-
dicating that the first 346 residues of Ulp1 are sufficient for
NPC localization. In contrast, a protein with just the NH2-
terminal 172 residues of Ulp1, ulp1-N172, which included
the intact NLS, concentrated primarily in the nucleus with-T
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out obvious nuclear rim staining. This suggests that in addi-
tion to the NLS, information within residues 173–346 also
contributes to proper nuclear envelope localization.
Together, these localization data indicate that information
within the NH2-terminal 346 residues of Ulp1 is both nec-
essary and sufficient for nuclear envelope localization of this
SUMO isopeptidase. This localization may be important for
modulating Ulp1 activity toward specific substrates (see Dis-
cussion). Interestingly, the NH2-terminal noncatalytic do-
mains of some Dubs can also affect their localization and
functional activity (Lin et al., 2000; Park et al., 2002).
Enhanced activity of Ulp1 COOH-terminal fragments 
toward Ulp2 substrates
When expressed at roughly endogenous levels, Ulp1 deriva-
tives lacking all or some of the NH2-terminal noncatalytic
domain failed to cleave many Smt3–protein conjugates effi-
ciently (Fig. 2 C). This suggested a positive regulatory role(s)
for the noncatalytic domain in substrate targeting. Remark-
ably, however, when we expressed these same NH2-termi-
nally truncated versions of Ulp1 at low copy in strains lack-
ing the other known desumoylating enzyme of yeast, Ulp2/
Smt4, a substantial reduction in Smt3–protein conjugates
was seen (Fig. 6 A). This was not true for full-length Ulp1
(or ulp1-C478) that was also expressed from a low copy
plasmid. Most noticeably, the ulp1-C275 and ulp1–204
proteins eliminated the majority of the Smt3–protein spe-
cies that characterize the ulp2  strain. Reduction of these
sumoylated species correlated with substantial suppression
of the ulp2  cellular phenotype, including temperature-sen-
sitive growth and hypersensitivity to hydroxyurea (HU) or
benomyl (Fig. 6 B). Growth on 0.1 M HU of ulp2  cells
transformed with ulp1-C275 or ulp1-C204 was indistin-
guishable from the ULP2 transformants; ulp1-C204 was a
slightly less effective suppressor of the high temperature and
benomyl sensitivities. Catalytic activity was required inas-
much as the inactive ulp1-C173 protein failed to reduce the
ulp2 -specific Smt3 conjugates or to restore growth under
the tested conditions.
We conclude that the noncatalytic NH2-terminal domain
of Ulp1 limits the activity of this enzyme toward the subset
of sumoylated proteins that are normally targeted by Ulp2.
This inhibitory function of the Ulp1 noncatalytic domain,
together with its positive role in targeting Ulp1 to other
Smt3–protein conjugates, allows for a sharp separation of
substrate specificities between these two SUMO isopepti-
dases in vivo.
Discussion
The two yeast SUMO isopeptidases, Ulp1 and Ulp2, have
distinct in vivo substrate specificities, and the data presented
here provide several important clues about the molecular un-
derpinnings of these differences. Based on both the present
results (summarized in Fig. 7) and our earlier work, it is clear
that Ulp1 has the ability to cleave a very broad range of
sumoylated substrates in vitro. However, at its normal levels
of expression in vivo the spectrum of proteins acted upon by
Ulp1 is more limited. A critical element in controlling Ulp1
activity appears to be its restricted localization: high levels
are normally only found at the nuclear envelope (NPC), and
loss of this constraint correlates with the ability to act on ad-
ditional sumoylated proteins. On the other hand, a failure to
localize to NPCs also may impair Ulp1 action toward many
of its normal targets, suggesting a specific requirement for
Ulp1 at the NPC. The noncatalytic domain of Ulp1 may
also control targeting to at least a subset of substrates by
means other than NPC binding. Surprisingly, the essential
function of Ulp1 in cell cycle progression does not require
the noncatalytic domain, indicating that certain substrates
can be recognized by the catalytic domain alone. We discuss
the implications of these data for both the evolution of mul-
tiple SUMO isopeptidases with diverse specificities and the
potential relationship between the yeast Ulps and those from
other eukaryotes.
Essential function of Ulp1
A significant finding of the current work is that the require-
ment of Ulp1 for cell viability can be separated from the
ability of the enzyme to localize to NPCs. This strongly sug-
gests that the essential cell cycle function of Ulp1 does not
involve regulation of nucleocytoplasmic transport at the
NPC, although we cannot completely exclude the possibil-
ity that a small amount of the NH2-terminally truncated
Ulp1 enzyme can still access the NPC, permitting an essen-
tial target there to be desumoylated. It seems more likely
that the protein or proteins that must by desumoylated by
Ulp1 for progression through G2/M phase need not be tar-
geted at the NPC. The catalytic domain (UD) is sufficient
to recognize and cleave these SUMO conjugates, which re-
main to be identified, although the N domain may contrib-
ute to their recognition.
When expressed as a separate domain, the catalytically in-
active UD of Ulp1 (ulp1-C204-C580S) behaves as a domi-
nant-negative lethal in yeast (Fig. 4 B). The degree of
growth inhibition is comparable to that seen with overpro-
Figure 7. Summary of Ulp1 functional 
elements. Boundaries represent maximal 
limits of segments necessary for the 
indicated property based on the deletions 
analyzed in the present work. See Results 
for details.T
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duced full-length ulp1-C580S. These data imply either that
high levels of the inactive UD can titrate an essential modu-
lator of Ulp1, which might only control activity against a
specific subset of targets, or that the inactive UD binds to
and blocks access to SUMO conjugates that must be cleaved
by Ulp1 for the cell cycle to progress. The UD of Ulp1 can
bind SUMO directly based on in vitro binding with bacteri-
ally expressed recombinant proteins (unpublished data).
Regulation of SUMO isopeptidase activity by the 
noncatalytic domain
When expressed at high levels, the isolated NH2-terminal
noncatalytic domain of Ulp1 also has a profound impact on
growth, even though this domain is not required for the es-
sential function of Ulp1 (Fig. 4). Growth impairment corre-
lates with excessive accumulation of sumoylated proteins in
these cells. Several distinct protein interaction techniques
failed to detect binding of the NH2-terminal domain of
Ulp1 with full-length Ulp1 or the COOH-terminal do-
main. We have preliminary data for interaction of the NH2-
terminal domain of Ulp1 with SUMO, but this interaction
appears to be weak (unpublished data). Weak binding to
specific substrates is also possible. A plausible explanation of
these results is that the noncatalytic domain can compete
with endogenous Ulp1 for SUMO-modified proteins (or
possibly for free SUMO or a regulator of Ulp1) and thereby
impede Ulp1-mediated cleavage.
Among the most surprising findings of the current work
was the robust suppression of ulp2  mutant defects by
NH2-terminally truncated forms of Ulp1 (Fig. 6). The
ulp2  complementation by ulp1-C275 and ulp1-C204
could be accounted for by their delocalized distribution
within the cell (Fig. 5), which would allow them to act on
Smt3 conjugates that are normally accessible only to Ulp2,
an enzyme that concentrates in the nucleus (Li and Hoch-
strasser, 2000). On the other hand, results with the ulp1-
C459 and ulp1-C449 proteins are not as easily explained
by this model. The ulp1-C459 protein, which still largely
concentrates at the nuclear envelope, reduced certain Smt3–
protein species in ulp2  cells and partially suppresses the
HU sensitivity of the mutant. In contrast, ulp1-C449,
which shows much less nuclear envelope localization, can-
not suppress any ulp2  phenotypic defects. One potential
explanation is that ulp1-C459, by virtue of being trans-
ported into the nucleus but only loosely associated with the
NPC, can access many Ulp2 substrates in the nucleus. It is
interesting that ulp1-C459 can suppress the HU sensitivity
of ulp2  cells but not its benomyl sensitivity. This might
reflect differences in the sumoylated proteins that must
be deconjugated, or in the extent of desumoylation of the
same protein that must occur, for cell recovery from these
two different kinds of cell cycle checkpoint arrest (Li and
Hochstrasser, 2000).
Earlier studies demonstrated that certain defects associated
with the ulp2  single mutant are suppressed in ulp1-ts
ulp2  double mutants (Li and Hochstrasser, 2000). There-
fore, another interpretation of ulp2  suppression by alleles
encoding NH2-terminally truncated Ulp1 is that these alle-
les exert a dominant-negative effect on Ulp1 action in the
ulp2  cells. However, several results argue against this view.
First, we see no growth defect or increase in SUMO conju-
gates in our wild-type strains that express ulp1-C204 or
ulp1-C275. Moreover, where these truncated Ulp1 proteins
do cause an increase in SUMO conjugates is in ulp1  cells
(Fig. 2 C), an effect that cannot be due to interference with
endogenous Ulp1. Finally, when cells bearing GAL-driven
alleles of GST–ulp1-C204 were grown on glucose (i.e., con-
ditions that allow very low levels of transcription), this res-
cues rather than impedes the growth of ulp1-ts cells at 37 C,
and GST–ulp1-C204 is not deleterious to growth under
these conditions in wild-type cells (Fig. 4 B), again arguing
against a dominant interfering effect.
The Ulp1 subfamily of desumoylating enzymes
Database searches with full-length yeast Ulp1 protein reveal
substantial similarity with the mammalian SENP1 and
SENP2/AXAM groups of Ulp isozymes, with up to 23%
identity/ 39% similarity over 580 residues. SENP1 and
SENP2 are  32% identical to one another over their entire
lengths. The similarities among these proteins extend be-
yond the UD itself. Intriguingly, full-length SENP2 is local-
ized to the NPC in mammalian cells (Hang and Dasso,
2002; Zhang et al., 2002). SENP2 localizes specifically to
the nuclear basket on the intranuclear side of the NPC. To-
gether, the sequence similarity of Ulp1 to SENP1 and
SENP2/AXAM, the related cellular localization patterns of
Ulp1 and SENP2, and the strong activity of this subgroup
of Ulp enzymes against a broad range of substrates (at least
when overexpressed) suggest that this group of enzymes rep-
resents a distinct functional subfamily of SUMO isopepti-
dases. In addition, alternative splicing generates at least three
distinct SENP2-related proteins in mammalian cells (Gong
et al., 2000; Nishida et al., 2001; Best et al., 2002). These
isoforms localize in strikingly different patterns within the
cell, underscoring the idea that subcellular distribution
could provide an important constraint on the activity of the
Ulp1 subfamily of enzymes.
Recently, it was reported that expression of one of the hu-
man SENP2-related splice variants, called SuPr-1, in yeast
ulp2  cells suppressed at least some of the phenotypic ab-
normalities of the mutant (Best et al., 2002). Although this
might be interpreted to mean that SuPr-1 is the functional
counterpart of Ulp2 (even though the SuPr-1 and Ulp2 se-
quences are highly diverged), our results suggest a different
possibility. The SuPr-1 protein is identical to SENP2 except
that it lacks the first 82 residues of the latter; the missing
NH2-terminal segment includes sequences necessary for
NPC localization (Hang and Dasso, 2002). Therefore,
SuPr-1 localizes more broadly, analogous to the NH2-termi-
nally truncated versions of Ulp1 that we generated. Some of
these truncated Ulp1 enzymes are able to suppress the ulp2 
growth abnormalities very efficiently (Fig. 6), as can moder-
ately overproduced full-length Ulp1 (Li and Hochstrasser,
2000). From these observations, we would suggest an alter-
native model for SuPr-1 suppression of ulp2  in which
SuPr-1 is mimicking NH2-terminally truncated Ulp1 in
these trans-species complementation assays rather than be-
ing the human version of Ulp2.
It is also instructive to compare some of the recent struc-
ture-function data on vertebrate SENP2 with our data onT
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yeast Ulp1. Hang and Dasso (2002) found that transient
transfection of an NH2-terminally truncated SENP2 that no
longer concentrated at the nuclear envelope caused a much
stronger drop in total cellular SUMO conjugates than did the
full-length protein. These conditions are roughly akin to the
overexpression of NH2-terminally truncated Ulp1 derivatives
in wild-type yeast cells (Fig. 4 A), which also greatly reduced
the concentration of sumoylated proteins. Although Hang
and Dasso (2002) inferred that NPC localization negatively
regulates SENP2 activity against bulk SUMO conjugates,
our data suggest a more complex picture at least for Ulp1. At
roughly physiological levels of expression (Fig. 2), loss of
NPC localization of Ulp1 does correlate with enhanced activ-
ity against one set of sumoylated substrates, those normally
cleaved by Ulp2 (Fig. 6 A), but it also correlates closely with
decreased activity against many of the normal targets of Ulp1
(Fig. 2 C). Hence, Ulp1 localization to the nuclear envelope
could positively regulate Ulp1 activity, particularly toward
many of its normal physiological substrates.
The simplest model to explain this positive role of Ulp1
localization to NPCs is that many of its substrates are only
accessible at these sites. The amount of Ulp1 in yeast cells is
relatively low (Li and Hochstrasser, 2000), so concentration
of the enzyme at places where its targets also congregate
could well increase its ability to process these SUMO conju-
gates efficiently. NPC localization raises the obvious possi-
bility that Ulp1 might play a direct role in NPC function
and nucleocytoplasmic trafficking. Indeed, a recent study
suggests a link between protein sumoylation in yeast and
transport through the NPC: both a ulp1 mutant and uba2
mutant were found to be impaired in nuclear protein import
(Stade et al., 2002). The authors concluded that Ulp1 only
contributes indirectly to nuclear transport by processing the
SUMO precursor because provision of processed SUMO to
the ulp1 mutant rescued nuclear import of the test substrate.
Because ulp1 suppression by supplemented SUMO was only
tested with an artificial transport substrate, it remains possi-
ble that natural transport intermediates, which might need
to go through additional steps, such as release from NPC
binding sites, might still require SUMO deconjugation
events at the NPC. Overproduced SUMO might also titrate
a negatively acting factor(s); for example, this factor could
bind sumoylated transport substrates tightly and prevent
their transport, an effect normally countered by Ulp1-medi-
ated desumoylation. This interpretation would predict that
provision of SUMO precursor (instead of the mature form)
would still suppress the transport defect of the ulp1 mutant,
but this was not tested.
While the present study was under review, another group
also reported that Ulp1 localizes to nuclear pores via its
NH2-terminal domain and showed that this is mediated by
specific karyopherins (Panse et al., 2003). Their localization
data are in general agreement with ours. However, Panse et
al. (2003) like Mossessova and Lima (2000) found that ex-
pression of their Ulp1 COOH-terminal domain is domi-
nant lethal. It is likely that this difference from our data re-
flects differences in the activity of the different C domain
constructs used. Our ulp1-C204 protein is shorter than the
one used in the above studies (C218), and we showed it has
reduced activity compared with full-length Ulp1 (Fig. 2).
We have tested the ulp1-N 403 (C218)–expressing allele in
our strains and confirmed its dominant-lethal effect (unpub-
lished data). A simple explanation would be that ulp1-C218
has a higher specific activity than ulp1-C204, so any loss of
constraints on its activity in vivo could cause a growth de-
fect. Supporting this view, stronger expression of ulp1-C204
is also dominant lethal (Fig. 4). Panse et al. (2003) restricted
their functional analysis to suppression of this (dominant)
lethality. In contrast, the ability of ulp1-C204 and several of
our other ulp1 alleles to support growth allowed us to evalu-
ate multiple potential functions of the Ulp1 N domain,
which revealed that this domain has additional roles beyond
NPC docking and that NPC docking of Ulp1 is not neces-
sarily essential.
Evolutionary diversification of Ulps
Deletion of the NH2-terminal domain of Ulp1 causes a re-
markable switch in its in vivo substrate specificity: many
normal Ulp1 targets are no longer processed efficiently,
whereas the majority of Ulp2 substrates are now cleaved by
the truncated Ulp1 protein (Figs. 2, 6, and 7). At higher
concentrations, the Ulp1 UD can cleave essentially all de-
tectable SUMO conjugates in yeast cells. It is easy to imag-
ine an “Ur-Ulp” of broad specificity that, through a process
of gene duplication and divergence, gave rise to multiple en-
zymes with more restricted and independently regulable
functions. Some of these might even have evolved to act on
Ubls other than SUMO.
S. cerevisiae, with only two SUMO isopeptidases of the
Ulp class, can be converted to something more like the pre-
sumed primitive condition simply by removing one of the
two enzymes, Ulp2, and reprogramming the other by re-
moval of its NH2-terminal regulatory domain. In the exam-
ple of the mammalian SENP2 gene, multiple specificities
can be generated from a single gene by alternative mRNA
splicing, with distinct subcellular locations for the product
of each splice variant. Adding to this complexity in mam-
mals is the presence of multiple additional members of the
Ulp/SENP family. Thus, we can expect even greater func-
tional specialization and diversification of Ulps in these or-
ganisms. It will be a challenge to find exact parallels between
the functions of these proteins and their orthologs in differ-
ent model eukaryotes such as yeast. Nevertheless, analysis of
the yeast SUMO isopeptidases should continue to shed light
on how the substrate specificity of this important group of
enzymes is controlled.
Materials and methods
Strains and plasmids
Media for yeast and bacterial growth and genetic procedures for manipu-
lating yeast and bacteria were described previously (Ausubel et al., 1989;
Guthrie and Fink, 1991). Yeast strains used in this study were MHY500 (a
his3- 200 leu2–3,112 ura3–52 lys2–801 trp1–1), MHY1380 (  his3- 200
leu2–3,112 ura3–52 lys2–801 trp1–1 ulp2 ::HIS3), and MHY1321 (a his3-
 200 leu2–3,112 ura3–52 lys2–801 trp1–1 ulp1 ::HIS3/ YCp50-ULP1)
(Chen et al., 1993; Li and Hochstrasser, 1999, 2000). The E. coli strain
JM101 was used for GST fusion protein expression and recombinant DNA
cloning (Ausubel et al., 1989).
All of the ULP1 deletions were derived from YCplac22-ULP1 (Li and
Hochstrasser, 1999) by homologous recombination in yeast. The ULP1
gene in the pACYC184 vector was used for PCR amplification with a
primer that annealed to the 3  end of the ULP1 ORF and a bridging primerT
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that contained sequences which fused elements bridging the sequence to
be deleted. The PCR products were cotransformed into wild-type MHY500
cells with Kpn21, Xba1-cut YCplac22-ULP1, and Trp
  colonies were se-
lected. Recombinant plasmids from the Trp
  colonies were recovered in E.
coli, and the segments derived from PCR amplification were sequenced to
verify that the correct deletion was introduced. This series of ulp1 dele-
tions encoded fusions of the NH2-terminal 19 residues of Ulp1 to se-
quences COOH-terminal to the desired deletion endpoint. We created
Ulp1 deletions C478 and C204 with only the initiator methionine and
found no differences in their ability to complement ulp1  lethality or in
their levels of expression.
DNA encoding the MYC9 epitope was incorporated into the YCplac22-
ULP1 and ulp1 -C478, -C459, -C449, -C275, -C204 and -C173 plasmids
by inserting a Kpn21, EcoRV-cut fragment from YRTAG310-ULP1-MYC9
into the recipient plasmids after treating them sequentially with EcoRI, Kle-
now polymerase, and Kpn21. YCplac22ulp1-N417, and -N172 were con-
structed by in vivo recombination. MYC9-tagged ulp1-N417, -N349, and
-N172 were constructed by in vivo recombination by cotransforming
Kpn21, XhoI-digested and gel-purified YCplac22-ULP1-MYC9 plasmid to-
gether with PCR-generated DNA fragments that deleted the desired
COOH-terminal region.
Plasmids for expression of GST-Ulp1 protein derivatives in E. coli were
made with the vector pGEX-KG and for expression in yeast with pEMBL-
GST (Baldari et al., 1987). For the latter, transcription was induced either
by growth in galactose or by contransforming with pGal4-ER-VP16 plas-
mid (Louvion et al., 1993), which allows induction of GAL-driven gene ex-
pression in glucose-containing media by addition of  -estradiol to 100
nM (final concentration). Plasmids pEMBL-GST-ULP1 and pEMBL-GST-
ulp1C580S were made by subcloning XhoI-BamHI fragments from pGEX-
ULP1 and pGEX-ulp1C580S (Li and Hochstrasser, 1999), respectively, into
BamHI, SalI-cut vector. Other GST fusion alleles were generated by PCR
and cloning into the pGEX-KG and pEMBL-GST vectors.
Immunofluorescence and Western immunoblot analyses
Immunofluorescence experiments were executed as described (Li and
Hochstrasser, 2000). The cells were incubated with a 1:100 dilution of
anti-MYC mAb (9E10; Covance), and secondary Oregon green–conjugated
anti–mouse IgG (Molecular Probes) was also diluted 100-fold in 1% BSA-
PBS. A drop of DAPI-containing mounting solution was applied to the air-
dried cells, and the samples were sealed under a cover slide.
Western immunoblot analysis was performed as described previously
(Li and Hochstrasser, 1999). Cells were harvested at OD600  1, and ex-
tracts were prepared by the alkaline lysis procedure. PVDF (Whatman)
membranes were bound with a 1:3,000 dilution of a partially purified anti-
Smt3 polyclonal antibody (Li and Hochstrasser, 1999) or a 1:3,000 dilu-
tion of an anti-MYC mAb (9E10; Covance). Membranes were stripped and
reprobed with an anti-PGK (1:4,000 dilution) mAb (Molecular Probes) to
evaluate protein loading.
Recombinant protein purification and enzyme assays
GST fusion proteins were expressed in E. coli JM101 by addition of IPTG to
1 mM for 3 h at 37 C. The fusion proteins were purified on glutathione-
agarose (Sigma-Aldrich) and eluted with glutathione. The purified recom-
binant proteins were dialyzed against 50 mM Tris-HCl, pH 8.0, 100 mM
NaCl, 1 mM dithiothreitol, and 30% glycerol. Purification and radiolabel-
ing of the substrate His6-Ub-Smt3-HA for the in vitro cleavage reactions
was described previously (Li and Hochstrasser, 2000).
Cleavage of 
35S-labeled His6-Ub-Smt3-HA was performed in reaction
buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1 mM
dithiothreitol and stopped by addition of SDS gel sample buffer and heat-
ing to 100 C for 3 min. The samples were separated by 12.5% SDS-PAGE,
and cleavage was quantitated using a Storm 860 Imager and ImageQuant
software (Molecular Dynamics). For kinetic measurements of processing,
concentrations of GST-Ulp1 and GST–Ulp1-C204 were 0.93 and 4.1 nM,
respectively. Substrate was present in 10
2–10
3 molar excess over enzyme.
Duplicate measurements at each reaction time point were made.
Pulse–chase analysis
Pulse–chase analysis was done as described previously (Chen et al., 1993).
Briefly, mid-log phase cultures were pulse labeled with 
35S-Translabel
(ICN) for 5 min at 30 C and chased in buffer containing cycloheximide
(0.5 mg/ml) and excess unlabeled methionine (10 mM). At various time
points, aliquots of cells were taken and heated at 100 C in a 1% SDS
buffer. Immunoprecipitation was performed after addition of 1 ml Triton
lysis buffer (150 mM NaCl, 50 mM Hepes, pH 7.5, 5 mM EDTA, 1% Triton
X-100) to 0.1 ml of SDS-lysed cells, using a 1:100 dilution of anti-HA mAb
(16E12; Covance). The antigen–antibody complex was precipitated with
protein G–agarose (Repligen).
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